Evidence map›Paper›PMID 41693978›Full record

ReviewWorld journal of gastroenterology2026

Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis.

Yao Chen, Qiang Zhang, Ming-Yang Zhang

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yao ChenDepartment of Pharmacy, Pengzhou Hospital of Traditional Chinese Medicine, Pengzhou 611930, Sichuan Province, China.
Qiang ZhangDepartment of Clinical Laboratory, Longgang District People's Hospital of Shenzhen, Shenzhen 518172, Guangdong Province, China.
Ming-Yang ZhangSchool of Basic Medical Sciences, Nanchang University, Nanchang 330006, Jiangxi Province, China. zmmyipuyuan@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, significantly threatens to global health. Despite considerable advances in diagnostic and therapeutic approaches in recent years, the prognosis for patients with HCC remains unsatisfactory. The emergence of artificial intelligence (AI), particularly deep learning technologies, offers new hope for improving the diagnosis and treatment of HCC. Researchers have extensively explored ways to integrate deep learning models into the clinical management of HCC patients, which provides a valuable foundation for developing more personalized treatment strategies. Compared with other detection methods, computed tomography (CT) has attracted significant research interest because of its comprehensive advantages, including wide availability and high resolution, making it well suited for AI-powered analysis. This review systematically integrates deep learning technologies for HCC based on CT imaging, while focusing primarily on tumor diagnosis, segmentation, treatment response prediction, and patient prognosis prediction. Moreover, we review popular deep learning networks in various fields and describe the advantages of these prevalent deep learning models for different applications. Furthermore, we discuss the outstanding challenges in applying deep learning to extract information from CT images for the diagnosis and treatment of HCC patients. These insights could provide guidance for subsequent studies.

Indexed as

Carcinoma, HepatocellularDeep LearningLiver NeoplasmsRadiographic Image Interpretation, Computer-AssistedTomography, X-Ray ComputedHumansPredictive Learning ModelsPredictive Value of TestsPrognosisTreatment OutcomeComputed tomographyDeep learningDiagnosisHepatocellular carcinomaPrognosisTreatment

Identifiers

PMID41693978
PMCPMC12897516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.